Systemic low-grade inflammation associated with obesity and metabolic syndrome is a strong risk factor for the development of diabetes mellitus and associated cardiovascular complications. This inflammatory state is caused by release of proinflammatory cytokines by macrophages, especially in adipose tissue. Long noncoding RNAs regulate macrophage activation and inflammatory gene networks, but their role in macrophage dysfunction during diet-induced obesity has been largely unexplored.
It has been recognized that this inflammatory state is primarily caused by macrophages undergoing phenotypic changes in response to excess lipid levels. 1, 2 Obesity induces a phenotypic switch in macrophages from an alternately activated M2 state to a classically activated proinflammatory M1 phenotype. 6 Studies by our laboratory and others have found that monocytes cultured with high glucose or advanced glycation end products have increased NF-κB activity and express higher levels of inflammatory genes such as C-C motif chemokine ligand 2 (Ccl2), Tnf, and interleukin-1β (Il1b), which promote monocyte activation and adhesion to endothelium. 7, 8 Recent studies have also associated obesity with a state of metabolic endotoxemia, described as elevated circulating levels of LPS (lipopolysaccharide) derived from gut microbiota, which likely induces M1 phenotypic switch in macrophages and causes inflammation. 9, 10 Obesity is associated with increased macrophage infiltration into adipose tissue, liver, and skeletal muscle. In particular, macrophage accumulation and polarization in adipose tissue during obesity plays a critical role in promoting systemic proinflammatory signaling and insulin resistance in a paracrine and likely endocrine fashion. 2, 3, 6, 11, 12 Notably, the metabolically activated macrophage could have a distinct proinflammatory phenotype distinct from the canonical M1/M2 paradigm. 13 Next-generation sequencing studies have identified thousands of transcripts called long noncoding RNAs (lncRNAs), which control gene expression, cellular phenotypes, developmental processes, and disease. 14, 15 LncRNAs can act in cis and in trans to affect gene expression through diverse mechanisms, including altering the recruitment of TFs and chromatin remodelers to specific genomic loci, acting as scaffolds in ribonucleoprotein particles, and regulating mRNA and microRNA functions/stability. 16 LncRNAs have also been identified as regulators of key macrophage functions including reactive oxygen species production, cholesterol homeostasis, inflammation, and phenotypic polarization. [17] [18] [19] [20] [21] We previously used RNA-seq to generate the first profile of lncRNAs differentially regulated in bone marrowderived macrophages (BMDMs) from diabetic db/db mice versus nondiabetic db/+ mice. 22 One of these lncRNAs, E330013P06, was upregulated under diabetic conditions and was shown to promote inflammation and macrophage lipid uptake. Recently, we showed that another diabetes mellitus-induced macrophage lncRNA, Dnm3os, controls macrophage inflammatory phenotype via trans mechanisms by interacting with nucleolin and through chromatin remodeling. 23 However, the potential role of lncRNAs in directing macrophage phenotype during diet-induced obesity remains unexplored.
Because lncRNA expression is highly specific to cell type and environmental cues, 24 there likely remain undiscovered functional lncRNA transcripts. In this study, we identified several novel lncRNAs in macrophages that are differentially expressed in a mouse model of dietinduced obesity and pre-diabetes mellitus. One of these lncRNAs, which we named as macrophage inflammation-suppressing transcript (Mist), was downregulated in peritoneal macrophages (PMs) and adipose tissue macrophages (ATMs) from diet-induced obesity mice as well as in human stromal vascular fraction isolated from adipose tissue from obese metabolically unhealthy donors relative to controls. Gain-and loss-of-function studies Nonstandard Abbreviations and Acronyms showed a functional role for Mist in anti-inflammatory and antiatherosclerotic phenotype of macrophages. Mechanistically, we identified that Mist interacts with PARP1 (poly ADP-ribose polymerase-1) in the nucleus and blocks PARP1 recruitment at inflammatory gene promoters. Disruption of this RNA-protein interaction promotes PARP1 recruitment and chromatin PARylation to enhance inflammatory gene expression. These data reveal that Mist is a novel protective lncRNA, and its loss contributes to metabolic dysfunction and proinflammatory phenotype of macrophages in the context of obesity and diabetes mellitus.
METHODS
The RNA-seq and microarray data have been made publicly available at the Gene Expression Omnibus with the accession numbers GSE126887 and GSE126839, respectively. All other supporting data are available within the article and in the Data Supplement.
Isolation and Culture of Primary Macrophages and Cell Lines
All animal experiments were performed with protocols approved by City of Hope Institutional Animal Care and Use Committee. Male C57BL/6J mice (8 weeks old) were fed with standard laboratory diet or high-fat diet (HFD, 60% kcal, Research Diets Inc, D12492i) for 12 or 16 weeks for PM and ATM collection, respectively. Male mice were used because female mice are relatively less susceptible to HFD-induced systemic inflammation and develop only some components of the metabolic syndrome. 25 Mice were weighed weekly and glucose tolerance tests performed immediately before macrophage collection ( Figure I in the Data Supplement). For glucose tolerance tests, mice were fasted for 4 to 6 hours but provided with water ad libitum; mice were then injected with sterilized D-glucose solution (0.1 g/mL stock) at 1 g/kg of body weight. Tail vein blood samples were collected at indicated time intervals post-injection and blood glucose levels determined using a glucometer. PMs were collected 4 days after intraperitoneal injection of 3% thioglycollate medium. BMDMs were obtained from femurs and tibia and cultured as described. 22 ATMs were obtained from epididymal visceral adipose tissue. Briefly, dissected fat pads were minced and gently agitated for 1 hour at 37°C in digestion buffer (100 mmol/L HEPES pH 7.4; 120 mmol/L NaCl; 50 mmol/L KCl; 5 mmol/L glucose; 1 mmol/L CaCl 2 ; and 1.5% BSA) containing 1 mg/mL collagenase D (Roche, Basel, Switzerland). Cell suspension was strained through 100 µm filter, centrifuged for 10 minutes at 4°C, and resuspended in 3 mL RBC lysis buffer. Twelve milliliters MACS buffer (PBS; 0.5% BSA; 2 mmol/L EDTA) was added, and cells were centrifuged again. Stromal vascular fraction (SVF) pellet was resuspended in 1 mL MACS buffer, and macrophages were positively selected using anti-F4/80 microbeads and MACS columns (Miltenyi Biotec, Bergisch Gladbach, Germany). RAW 264.7 (RAW) mouse macrophage cell line (ATCC TIB-71) was used for additional experiments. Where indicated, cells were treated with LPS (100 ng/mL). Human THP-1 monocytes (ATCC TIB-202) were differentiated into macrophages with phorbol 12-myristate 13-acetate at 20 ng/mL for 48 hours before LPS treatment as indicated.
Human Subjects and Tissue Processing
All human studies were conducted according to approved Institutional Review Board protocols. De-identified human RNA was used for gene expression studies. Visceral adipose tissue samples were collected from the greater omentum at the time of endoscopic hernia repair or nissen fundoplication (nonobese subjects, body mass index <30) and gastric bypass surgery (subjects with obesity, body mass index >40) between the years 2011 and 2013. A nonhuman subject research determination was granted by the University of Maryland, Baltimore, Institutional Review Board (HP-00058301) to J.A. Deiuliis where the human quantitative polymerase chain reaction (qPCR) data was generated and RNA sample-specific biometric characteristics compiled. A nonhuman subject research determination was also granted by Case Western Reserve University Institutional Review Board (STUDY20190017). Fasting blood was drawn on the morning of surgery, and blood chemistry values are provided in Table I in the Data Supplement. After excision, the omental adipose tissue sample was rinsed with PBS, minced, and digested in sterile solution of collagenase type II from Clostridium histolyticum (1 mg/mL) at 37°C. The adipose tissue digest was passed through a cell strainer, centrifuged at 300g for 10 minutes. The resulting SVF pellet was washed with ice-cold PBS and homogenized in TRIzol (Life Technologies, Carlsbad, CA). RNA was further purified using total RNA isolation system (Exiqon, Foster City, CA). RNA quality was determined by Bioanalyzer (Agilent, Santa Clara, CA); only samples with RIN scores >7 were used.
RNA Isolation and Quantitative Reverse Transcription PCR
Total RNA was isolated from mouse PMs using TRIzol and from BMDMs, ATMs, RAW cells and THP-1 cells using RNeasy Mini Kit (Qiagen, Hilden, Germany). cDNA was synthesized with high capacity cDNA Reverse Transcription kit (Thermo Fisher Scientific, Waltham, MA). Gene expression was analyzed using 7500 Fast Real-Time PCR system (Applied Biosystems, Foster City, CA) with KAPA SYBR FAST qPCR Master Mix (Roche, Basel, Switzerland) and gene-specific primers ( Table II in the Data Supplement) in triplicate. Relative gene expression levels were determined using 2 −ΔΔCt method, normalized against internal controls Actb (mouse) and GAPDH (human) unless specified otherwise.
RNA Sequencing, Ribosomal Profiling, and Downstream Analysis
Whole transcriptome analysis of RNA from mouse PMs was performed using total RNA depleted of rRNA (Ribo-Zero, Illumina). Paired-end libraries were prepared and sequenced at City of Hope Integrative Genomics Core using an Illumina HiSeq 2000 system. Reads were mapped to the mouse genome assembly mm9 using TopHat2 aligner. Cufflinks and Cuffmerge software 26 was used to generate de novo transcript assemblies. Novel genes were classified using the pipeline in Figure IIA in the Data Supplement as described 22 ; briefly, transcripts that overlapped with RefSeq genes of mouse and 7 other organisms (human, chimp, rat, rabbit, orangutan, rhesus, and marmoset) were filtered out. Filtered transcripts were further assessed for potential open reading frames by using PhyloCSF and searching PfamA/B databases. Multiexonic transcripts with a score of >100 or with encoded PfamA/B protein domains were classified as novel protein-encoding transcripts. Transcripts of >200 bp containing at least 2 exons, having a PhyloCSF score of <100 and lacking PfamA/B domains, were defined as novel lncRNAs. Gene counts were generated with HTseq 27 and differentially expressed genes (DEGs) identified with DEseq2. 28 Biological functions and network analysis of DEGs with FPKM (fragments per kilobase per transcript) >1 and P<0.1 (481 genes) were performed using ingenuity pathway analysis (IPA, Qiagen) and DAVID (Database for Annotation, Visualization and Integrated Discovery) gene ontology analysis. Raw sequencing data and gene counts are deposited to NCBI GEO (Gene Expression Omnibus) repository GSE126887. For ribosomal profiling data, raw data from Wang et al 29 was aligned to mm9 genome assembly using HISAT2, and gene FPKM values were generated using Cufflinks.
Nuclear Fractionation
RAW cells (≈40 million) were detached from plates by accutase treatment (Innovative Cell Technologies, San Diego, CA). Cells were washed in ice-cold PBS twice and resuspended in 1 mL of Lysis Buffer B (10 mmol/L Tris-HCl, 140 mmol/L NaCl, 1.5 mmol/L MgCl 2 , and 0.5% NP-40, RNAse inhibitor). Nuclei were pelleted at 1000 g, and supernatant containing cytoplasmic fraction was collected. Nuclei were resuspended in Lysis Buffer B and slowly mixed while adding 100 µL detergent stock (3.3% sodium deoxycholate, 6.6% tween 20). Nuclei were incubated on ice for 5 minutes, pelleted, and washed with Lysis Buffer B. RNA from remaining nuclear and cytoplasmic fractions was extracted using Trizol followed by RNA cleanup using Qiagen RNEasy columns. cDNA was synthesized using High Capacity cDNA Reverse Transcription kit and quantified by real-time (RT)-qPCR.
RNA-Fluorescent In Situ Hybridization
Mist subcellular localization was visualized using ViewRNA ISH Cell Assay kit (Affymetrix, Santa Clara, CA) and customdesigned Mist probe. Macrophages were fixed according to manufacturer's protocol, with 4% formaldehyde for 30 minutes at protease dilution of 1:2000. Images were acquired on Zeiss Observer II microscope and processed with ZEN Blue software and ImageJ.
GapmeR-Mediated Mist Knockdown (In Vitro and In Vivo) and Microarray Profiling
RAW cells were transfected with antisense locked nucleic acidmodified GapmeRs (Exiqon) targeting Mist or a nontargeting control using Lipofectamine RNAiMAX (Invitrogen), and RNA was collected 48 hours post-transfection. For initial GapmeR screening, cells were transfected at 100 nmol/L. Subsequent experiments showed optimal knockdown at 50 nmol/L, which was used for all other Mist knockdown experiments in RAW cells. Global gene expression was analyzed using GeneChip Mouse Gene 2.0 ST whole-transcript array. DEGs were identified as absolute fold change >1.5 and P<0.05. Gene ontology and TF enrichment of DEGs was performed using DAVID 30 and ENRICHR, 31 respectively. Enriched TFs were identified from chromatin immunoprecipitation (ChIP)-X experiments culled from ENCODE (Encyclopedia of DNA Elements) and ChEA databases, as described. 31 Microarray data are deposited to NCBI GEO repository GSE126839. For in vivo knockdown of Mist, GapmeRs were administered to male standard diet-fed WT C57BL/6 mice (8 weeks old) intraperitoneally at 5 mg/kg as described under Results.
Modified LDL Uptake Assays
DiI-ac-LDL (acetylated low-density lipoprotein labeled with 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine) was added at 10 µg/mL to RAW macrophages plated in DMEM+0.1% BSA. After 4 hours at 37°C, fluorescent images were collected with Evos FL Cell Imaging System (ThermoFisher Scientific). Alternately, cells were washed, detached using Accutase and resuspended in staining buffer+DAPI, and LDL uptake assessed by flow cytometry using BD LSRFortessa cell analyzer. Additional quantitative analysis was performed by comparing normalized fluorescence of cell lysates following published protocol. 32 5′ and 3′ Rapid Amplification of cDNA Ends PCR, Cloning, and Overexpression of Mist in Macrophages 5′ and 3′ Rapid amplification of cDNA ends experiments were performed using FirstChoice RLM-RACE Kit (ThermoFischer). After identification of transcript ends, full-length Mist was amplified from RAW cell cDNA and cloned into pcDNA3.1(+) and in reverse orientation in pcDNA3.1(−) expression vectors using In-Fusion HD Cloning (Clontech). Transient overexpression in RAW cells was performed by transfection with Lipofectamine LTX (0.3 µg DNA/well in 24-well plates) and RNA collected after 72 hours.
ELISAs in BMDMs
BMDMs were transiently transfected by electroporation using Mouse Macrophage Nucleofector Kit (Lonza). Forty-eight hours post-transfection, complete medium was replaced with 0.5% FBS containing medium. Twenty-four hours later, supernatants were collected, spun down, and subjected to ELISA cytokine analysis for TNF-α and IL-1β (R&D Systems). RNA was collected for RT-qPCR analysis.
Chromatin Immunoprecipitation
ChIP was performed as previously described. 23, 33 Sheared and precleared chromatin (1×10 6 cell equivalents) was immunoprecipitated with 3 µg of H3K4me3 (H3 lysine-4 monomethylation) antibody (Millipore 17-614) or control Rabbit IgG, overnight at 4°C. ChIP-enriched DNA was analyzed by qPCR with promoter-specific primers ( Table II in the Data Supplement). ChIP DNA enrichment was first calculated by % Input and then represented as fold-over IgG.
ChIP assays for PAR (poly(ADP)-ribosylation; Trevigen anti-PAR Cat number 4335-MC-100, Lot number 39816F17) and PARP1 (Abcam Anti-PARP1, ab227244, Lot GR3226439-13) were performed with modified protocol to minimize generation of PAR artifacts. 34 Sonication was increased to 16 cycles to achieve similar fragment sizes, as verified by reverse crosslinking and running sheared chromatin on agarose gel. ChIP enrichment relative to input (% Input) was calculated using the formula 100×2 (Ct [adjusted input to 100%]−Ct [IP]) .
RNA Pulldown Coupled With Mass Spectrometry to Identify Mist-Interacting Proteins
RNA pulldown was performed as previously described with some modifications. 23, 35 Briefly, precleared nuclear extract from RAW macrophages (1 mg) was incubated with biotin-labeled full-length Mist sense or antisense RNA probes (3 µg) and tRNA (30 µg) at 4°C for 2 hours. Washed Streptavidin agarose beads were added to each binding reaction and further incubated at 4°C for 2 hours. Beads were washed, RNA-protein complexes were resolved on SDS-PAGE, bands were excised, and proteins were identified by Mass Spectrometry at City of Hope's Mass Spectrometry Core. Scaffold (Proteome Software Inc, Portland, OR) was used to validate MS/MS-based peptide and protein identifications. Peptides were identified using Scaffold (Proteome Software Inc, Portland, OR) and were accepted if they could be established at minimum 99.0% probability by the Scaffold Local FDR algorithm. Protein identifications were accepted if they could be established at minimum 99.0% probability and contained at least 2 identified peptides. For validation experiments, eluted proteins were also analyzed by Western blotting with antibodies targeting PARP1 (Abcam, ab227244, Lot GR3226439-13) and HNRNPA3 (heterogeneous nuclear ribonucleoprotein A3; Proteintech, Cat number 25142-1-AP).
Nuclear RNA Immunoprecipitation
Native RNA immunoprecipitation (RIP) was performed using published protocol. 36 Briefly, nuclear lysates from RAW cells were diluted in RIP buffer and incubated with indicated antibodies at manufacturer-recommended dilutions. RNA-protein complexes were captured on magnetic-IgG beads, and bound RNA was isolated and analyzed by RT-qPCR. Antibodies used were PARP1 (1:100), HNRNPA3 (1:1000), SUPT16H (1:500, Proteintech, Cat number 20551-1-AP), SMARCA5 (1:500, Proteintech, Cat number 13066-1-AP), and Rabbit IgG control (1:1000). Cross-linked RIP was performed following published protocol. 37 
Statistical Analysis
Gene expression values are expressed as mean+SD. Unless noted otherwise, statistical significance was calculated using unpaired 2-tailed Student t test to compare 2 groups or ANOVA followed by Fisher least significant difference test to compare multiple groups using Graphpad PRISM 7.0 software. All expression values from RT-qPCR were log-transformed and checked for normal distribution before statistical testing. Post hoc analysis of MIST expression from human SVF was calculated using Student t test or 1-way ANOVA followed by Tukey multiple comparisons test. Before correlation testing for human SVF data, health parameters were first checked for Gaussian distribution using D' Agostino and Pearson normality test, followed by Pearson correlation. Differences in health parameters across cohorts were tested using Welch test for normally distributed parameters and Mann-Whitney test for non-normal distributed parameters. To exclude treatment intervention as a variable affecting metabolic health, individuals prescribed metformin or thiazolidinedione were excluded from analysis. P<0.05 were considered statistically significant.
RESULTS

LncRNA Mist Is Downregulated in Macrophages From HFD-Fed Obese Mice
To examine whether key macrophage lncRNAs are dysregulated during obesity and can contribute to increased inflammation, we used thioglycollate-elicited PMs from C57BL/6 mice fed HFD for 12 weeks and control littermates on standard laboratory diet (ND). HFD led to significant increases in body weight and impaired glucose tolerance (Figure IA through IC in the Data Supplement). RNA-seq analysis of total RNA from these PMs followed by de novo transcriptome assembly revealed 510 DEGs in macrophages from HFD versus ND mice ( Figure 1A) , the majority of which were protein-coding ( Figure 1B ). As expected, HFD-induced genes showed enriched association with inflammatory response (Figure ID through IE in the Data Supplement).
We identified 37 novel macrophage lncRNAs from this data set using our data analysis pipeline ( Figure  IIA in the Data Supplement), of which 12 were differentially expressed in HFD-fed mice ( Figure IIB in the Data Supplement). One of these lncRNAs, XLOC_019580, which we renamed Mist, overlaps with cDNA AK078702 on chromosome 3 originally identified in the FANTOM (Functional Annotation of the Mammalian Genome) consortium 38 (Gencode ID: Gm38335) but lacks an overlapping Refseq annotation and has not been previously studied. Mist was chosen for further study because it is an intergenic lncRNA that lies ≈5.6 kb downstream of the protein-coding gene fatty acid binding protein 5 (Fabp5; Table III in the Data Supplement), an intracellular lipid chaperone with known roles in atherosclerosis, insulin sensitivity, and inflammation. 39, 40 Expression of Mist and Fabp5 were reduced in macrophages from HFD mice compared with control mice, which was confirmed by RT-qPCR ( Figure 1C and 1D). Because metabolic syndrome is associated with increased inflammation, we examined whether Mist was similarly regulated by proinflammatory M1 stimuli. PMs treated with LPS in vitro also showed downregulation of Mist and Fabp5, and PMs from HFD mice showed further reduction in Mist expression ( Figure 1C and 1D ). Interestingly, Mist locus also overlaps with enhancer marks histone H3K4me1 and H3K27ac (lysine-27 acetylation; Figure 1E ), suggesting a potential function related to chromatin and gene regulation.
ATMs are considered important regulators of obesity-induced inflammation and insulin resistance. To determine the expression pattern of Mist in ATMs, we isolated epididymal visceral white adipose tissue after 16 weeks HFD feeding, followed by extraction of RNA from F4/80 + cells enriched from SVF. Interestingly, expression of Mist was also reduced in ATMs from HFD-fed mice compared with ND, while Tnf, Il1b, and Il10 were upregulated ( Figure 1F ), as expected. 13 Mist Is a Nuclear Transcript That Lacks Coding Potential RT-qPCRs of subcellular fractions showed that Mist is localized primarily in the nuclei of macrophages (Figure 1G ). This was further confirmed using RNA-fluorescent in situ hybridization with branched-DNA signal amplification probes, which showed Mist foci overlapping with nuclear DAPI staining in both primary PMs and RAW macrophage cell lines ( Figure 1H and 1I ). Cells were also probed for Ppia as a positive cytoplasmic RNA control, and cells with no probe were processed in parallel as negative controls ( Figure IIIA 
Mist Knockdown Upregulates Genes Involved in Inflammation and Lipid Metabolism
Metabolic syndrome dysregulates macrophage polarization and promotes proinflammatory M1 phenotype. To test our hypothesis that Mist regulates genes involved in macrophage polarization and function, we employed a loss-of-function approach using LNA-modified ASOs (antisense oligonucleotides, GapmeRs). We tested 4 different GapmeRs targeting Mist in RAW macrophages ( Figure VA and VB in the Data Supplement) and used the most effective GapmeR (ASO-Mist) relative to control Gapmer (ASO-NC) in succeeding knockdown experiments. In subsequent experiments, we used optimized transfection conditions to achieve close to 80% knockdown in RAW cells ( Figure VC (Figure 2A ). Gene ontology analysis showed an enrichment of innate immune response, TNF production, and macrophage foam cell formation ( Figure 2B ) in upregulated genes and those related to lipid metabolism and cholesterol esterification among downregulated genes ( Figure 2C ). Upregulated gene promoters showed enrichment of TF IRF8 ( Figure 2D ), while the downregulated gene set was significantly enriched for targets of TF CEBPβ (Figure 2E ), important drivers of M1-and M2-specific gene expression, respectively. 41, 42 Further RT-qPCR validation showed that Mist knockdown also suppressed expression of its neighboring gene Fabp5 ( Figure 2F ). Interestingly, proinflammatory cytokines (Tnf, Il6, Il1b, and Ccl2) associated with macrophage M1 phenotype were upregulated by Mist knockdown, while markers of macrophage M2 activation such as Egr2, Cd83, 43 and Ppard were suppressed by Mist knockdown. Mist knockdown also enhanced expression of Il10 ( Figure 2F) , which is often upregulated in activated macrophages to curtail excessive inflammatory response. 44 Notably, scavenger receptor Cd36 was also highly induced on Mist knockdown ( Figure 2F ). Overall, these data show that Mist knockdown increases genes associated with inflammation and M1 polarization but inhibits markers associated with alternative activation, suggesting an antiinflammatory function for Mist in macrophages.
To further determine whether Mist silencing in macrophages causes gene expression changes that resemble those induced by HFD, we compared DEGs on Mist knockdown with DEGs identified in our RNA-seq data from HFD-fed PMs. The 2 DEG lists shared a significant number of up-and downregulated genes, with hypergeometric P values of 2.47×10 −4 and 2.15×10 −5 , respectively. To account for the differences in confidence threshold distribution between these data sets, we also used rank-rank hypergeometric overlap 45 to compare expression profiles and identify shared gene expression patterns ( Figure 2G ). The rank-rank hypergeometric overlap heatmap shows both a global trend of positive correlation as well as specific gene sets similarly enriched in both HFD and Mist knockdown.
Loss of Mist Increases Modified LDL Uptake In Vitro and Increases Inflammatory Genes in Standard Diet-Fed Mice In Vivo
CD36 promotes macrophage foam cell formation via uptake of oxidized LDL and is highly expressed in macrophages in atherosclerotic lesions. 46 CD36 is also upregulated in ATMs during obesity 13 and in PMs from our HFD-fed mice. Our observations that Mist negatively regulates Cd36 expression and genes associated with cholesterol esterification led us to hypothesize that Mist influences modified LDL uptake. Indeed, Mist silencing significantly increased ac-LDL (acetylated low-density lipoprotein) uptake ( Figure 3A and 3B) .
To investigate whether Mist has similar anti-inflammatory functions in macrophages in vivo, we injected ASO-Mist and ASO-NC GapmeRs into normal C57BL/6J mice and examined gene expression in thioglycollateelicited PMs 5 days later ( Figure 3C ). Two ASO-Mist injections were sufficient to confer significant reduction in Mist expression versus PMs from ASO-NC injected mice ( Figure 3D ). Similar to our observations in vitro, Mist silencing in vivo caused a reduction in Fabp5 expression ( Figure 3E ), significant upregulation of M1 genes Tnf, Il1b, Il6, and Nos2 ( Figure 3F through 3I) , and downregulation of important M2 marker Cd206 ( Figure 3J ) and driver of alternative activation Il4 (Figure 3K ), indicating that Mist knockdown promotes M1 polarization and proinflammation in vivo.
Mist Gain-of-Function Leads to Reduction in Inflammatory Response and Increases ac-LDL Uptake
We next examined whether, conversely, Mist overexpression can have protective effects in macrophages. Transfection of RAW macrophages with plasmids expressing Mist_v1 and Mist_v2 splice variants ( Figure IIIH and IIII in the Data Supplement) showed that Mist overexpression (6-fold increase) reduced basal levels of genes associated with inflammation and lipid metabolism ( Figure 4A through 4D), most of which were upregulated by Mist knockdown (Figure 2F ). Additionally, Mist overexpression partially blunted the LPS-mediated induction of inflammatory response in RAW cells ( Figure VIIA through VIID in the Data Supplement). This effect was even more pronounced in primary BMDMs on Mist_v1 overexpression, which inhibited the expression of Cd36 and key inflammatory genes in response to LPS treatment ( Figure 4E through 4J), as well as secretion of inflammatory cytokines IL-1β and TNF-α ( Figure 4K and 4L) . Additionally, ectopic overexpression of Mist inhibited ac-LDL uptake ( Figure 4M and 4N) , demonstrating a potential role for Mist in protecting against macrophage foam cell formation. These results collectively indicate that changes in Mist expression can influence genes associated with 
Mist Effects Are Only Partially Mediated by Nearby Fabp5
Because lncRNAs can affect expression of nearby genes in cis, and Fabp5 was downregulated after Mist knockdown ( Figure 2F and 3E) , we examined whether Mist functional effects on macrophage phenotype were due to Fabp5 downregulation. Fabp5 knockdown using siRNAs in RAW cells increased expression of Il1b, Il10, and Ccl2 but had no effect on Mist and several other Mist-regulated genes ( Figure VIIIA 
Mist Interacts With PARP1 to Epigenetically Influence Inflammatory Gene Expression
LncRNAs often exert their functions via interactions with nuclear proteins and coordinately modify nucleosomes and influence chromatin structure. 16 To understand how Mist might mechanistically exert its effects in macrophages, we performed RNA pulldown experiments using biotinylated Mist sense or antisense RNA (Mist-AS) probes followed by mass spectrometry to find candidate nuclear protein interactors of Mist (Figure 5A) . The probes pulled down a total of 296 proteins, of which 86 had normalized spectra counts enriched >2-fold compared with Mist-AS probe (Table V in the Data Supplement). We focused on PARP1 and HNRNPA3 proteins which were highly enriched in Mist pulldown due to their reported roles in cellular function and inflammation regulation. 47, 48 We validated the mass spectrometry results using RNA pulldown Figure 5B) . These interactions were further assessed by native RIP followed by RT-qPCR. PARP1 showed strong interaction with Mist, while other candidate proteins failed to immunoprecipitate with Mist ( Figure IXB through IXC in the Data Supplement). Additional UV crosslink RIP experiments confirmed the enrichment of Mist in PARP1 co-purified RNA ( Figure 5C ). Macrophage lncRNA Dnm3os was used as a control in Figure 5B and 5C, in addition to U6 and Ppia in Figure 5C . PARP1 is a known transcriptional regulator and modifier of chromatin architecture. TNF-α-induced NF-kB transcriptional activation also involves PARP1 activity. 49 Enrichment of PARP1 and histone PARylation at promoters is highly correlated with enrichment of H3K4me3, a chromatin mark associated with active transcription. 50 Notably, IPA Upstream Regulator Analysis of Mist-regulated genes (Figure 2A) predicted an increase of PARP1 activity (bias-corrected z-score=2.18, P=5.57×10 −11 ) but our microarray data showed that Mist knockdown did not affect Parp1 mRNA levels, suggesting that Mist might regulate PARP1 function. Because lncRNAs can inhibit binding of transcriptional machinery at promoters by acting as decoys, 51 we hypothesized that Mist might inhibit PARP1 binding and activity at promoters of proinflammatory genes to repress their expression via epigenetic mechanisms. Indeed, ChIP assays showed that Mist knockdown significantly increased chromatin PARylation ( Figure 5D ), PARP1 occupancy ( Figure 5E ), and H3K4me3 ( Figure 5F ) at promoters of key Mistresponsive genes, relative to control GapmeR. Irf7, Irf3, and Fabp5 promoters showed increased PARylation on Mist knockdown ( Figure 5D ) but did not show increased PARP1 occupancy (Figure XA through XC in the Data Supplement), which could be due to cooperation with other chromatin marks at these promoters. Overall, these results clearly demonstrate that Mist regulates PARP1 function at chromatin in macrophages.
MIST Levels Are Inversely Correlated With Obesity and Metabolic Dysfunction in Humans
While most lncRNAs have evolutionarily conserved genomic locations, promoter sequences, and tissue-specific expression patterns, levels of sequence conservation are variable and often less significant compared with protein-coding genes. 52 The predicted human MIST locus shows evolutionarily conserved regions overlapping with the aligned exons and promoter from mouse (Figure XIA in the Data Supplement). Transmap, a cross-species transcript alignment tool, 53 shows 86.7% alignment of Mist-overlapping RNA Gm38335 to its syntenic region in the human genome with 67.1% conserved sequence identity. Notably, this region overlaps with 4 human ESTs, further evidence of an underlying transcript in humans ( Figure XIB in the Data Supplement). Human monocyte data from ENCODE shows a similar histone signature as seen in mouse macrophages. Additionally, PhyloCSF tracks overlapping and flanking this locus show no evidence of protein-coding potential in any reading frame ( Figure XIB in the Data Supplement).
We used NCBI's Evolutionarily Conserved Regions Browser to design RT-qPCR primers for human orthologous MIST and could amplify human MIST using RNA from human THP-1 monocytes and primary human monocyte-derived macrophages. We next examined whether MIST exhibits a similar expression pattern as its mouse homolog. Indeed, LPS treatment of phorbol 12-myristate 13-acetate-differentiated THP-1 macrophages caused a significant reduction in MIST expression ( Figure 6A ), similar to that seen in mouse macrophages ( Figure 1C) . Notably, treatment with anti-inflammatory cytokine IL-4 caused an increase in MIST expression in macrophages differentiated from CD14 + monocytes from healthy donors (4.21±1.26-fold over control, n=6; P<0.01). However, we did not observe similar results in mouse macrophages.
We next examined whether changes in MIST expression in vivo are associated with human obesity and metabolic dysfunction. To examine relevance to human clinical obesity, insulin resistance, and metabolic syndrome, we compared human MIST RNA levels in SVF isolated from omentum of patients with obesity undergoing bariatric Table I in the Data  Supplement) . MIST expression tended to be lower in SVF from all subjects with obesity versus nonobese individuals ( Figure XII in the Data Supplement). Furthermore, when individuals with obesity were further stratified into metabolically unhealthy obese and metabolically healthy obese groups (defined in Table I in the Data Supplement), MIST expression was significantly downregulated in metabolically unhealthy obese relative to metabolically healthy obese and nonobese individuals ( Figure 6B ). Additionally, patients with HDL levels <40 mg/dL showed significantly lower levels of MIST (Figure 6C) . Among the obese cohort, MIST levels were also negatively correlated with individual body mass index and fasting insulin levels but positively correlated with QUICKI (Quantitative Insulin-Sensitivity Check Index) index of insulin sensitivity ( Figure 6D through 6F) , providing further evidence that repressed MIST expression in human ATMs correlates with increased severity of obesity and metabolic dysfunction.
DISCUSSION
Because macrophages are important players in obesityinduced inflammation, metabolic syndrome, subsequent diabetes mellitus, and its complications, it is critical to identify the regulatory factors involved in macrophage dysfunction during obesity and insulin resistance. Here, we identify a previously unknown lncRNA, Mist, that is downregulated in multiple macrophage populations from obese insulin resistance mice and SVF from metabolically unhealthy obese humans. Mist is primarily localized in the nucleus and transcribed from a putative enhancer region based on H3K4me1 and H3K27ac enrichment but appears to affect gene expression beyond its immediate genomic neighborhood. Mist inhibits macrophage inflammatory response and foam cell formation, suggesting a protective role that is lost on metabolic dysfunction during obesity. We found that knockdown of Mist with specific GapmeR antisense oligonucleotides could enhance the expression of macrophage inflammatory genes in vitro as well as in vivo in normal mice, supporting the anti-inflammatory role of Mist under normal conditions that is lost during diet-induced obesity. This was further supported by our reciprocal data showing overexpression of Mist in vitro attenuates the inflammatory effects of LPS in cultured macrophages, including bone marrow macrophages. However, we were unable to test whether Mist overexpression has similar protective effects in vivo in HFD-fed mice because the technology for lncRNA overexpression in vivo is not yet mature.
We also identified a human ortholog of MIST that was expressed in human macrophages. Interestingly, previously published data of chromatin accessibility across various stages of hematopoietic differentiation 54 shows open chromatin at the conserved MIST promoter locus in most progenitor cells, but among 6 mature differentiated populations, open chromatin is only present in monocytes ( Figure XIII in the Data Supplement, red boxed area), suggesting monocyte/macrophage-type specific expression of MIST in humans. Importantly, in human omentum SVF, we found MIST expression was not only downregulated in metabolically unhealthy obese compared with metabolically healthy obese and nonobese donors but also showed a negative relationship with severity of obesity and positive correlation with markers of metabolic health and insulin sensitivity. One limitation of our study is that SVF contains a heterogeneous mix of immune and stem cells. Additionally, human MIST is unannotated in most gene databases, making it difficult to validate the specificity of MIST expression in human macrophages. However, overall, these results suggest that MIST levels could play a role in altering macrophage phenotype under obese conditions in humans. A number of human macrophage lncRNAs have recently been associated with cardiometabolic disorders, 55 and we also found human orthologs of lncRNAs E330013P06 and DNM3OS in human monocytes/macrophages that were upregulated under diabetic conditions. 22, 23 These reports together with our current data suggest macrophage lncRNAs could be novel therapeutic targets for human metabolic disease and diabetes mellitus.
Mist affected the expression of its neighboring gene Fabp5 in a manner consistent with cis-mediated regulation 56 ; however, Fabp5 silencing recapitulated some but not all the effects of Mist knockdown. Although our results do not preclude mechanisms involving underlying regulatory elements including enhancers at the Mist locus, our data indicate a functional role for the Mist transcript itself. Further studies are necessary to elucidate the overlap between these potential mechanistic pathways.
Interaction with histone modifiers is a well-established epigenetic mechanism for lncRNA regulation of putative target gene transcription. Our RNA-pulldown experiments identified PARP1 as a lead Mist-interacting partner. Furthermore, Mist knockdown potentiated PARP1 recruitment and PARylation of chromatin at inflammatory gene promoters. PARP1 is involved in maintenance of multiple chromatin accessibility states, including euchromatin at genomic loci of active genes. 50 PARylation of histones can help maintain H3K4me3 at the transcription start site of active genes. 57 We observed increased H3K4me3 at some but not all gene promoters tested, suggesting potential involvement of other histone modifications regulated by PARylation. 50 Importantly, PARylation was increased at all tested Mist targets after Mist knockdown, indicating that interaction with PARP1 plays key role in gene regulation by Mist. Previous studies showed PARP1 binding to lncRNAs 58 ; however, only recently has PARP1 interaction with an lncRNA shown to promote PARP1 recruitment and histone PARylation at target gene promoters. 59 In contrast, our data shows that Mist sequesters or blocks PARP1 binding and inhibits PARylation at inflammatory gene promoters. This is reminiscent of other lncRNAs with opposing functions on chromatin modifiers, such as lncRNAs Kcnq1ot1 and ROR acting on histone methyltransferase G9a as recruiter 60 or decoy, 51 respectively. Although several proinflammatory macrophage lncRNAs have been reported, much less is known about antiinflammatory lncRNAs, especially under insulin-resistant conditions. Our data show for the first time that a novel lncRNA, Mist, may restrain inflammation under normal conditions, and its downregulation during obesity can derepress inflammatory pathways at least in part via epigenetic mechanisms and contribute to metabolic dysfunction ( Figure 6G ). Thus, macrophage lncRNAs such as Mist and their targets should be evaluated as potential therapeutic targets for insulin resistance/pre-diabetes mellitus, inflammatory metabolic disorders, and diabetes mellitus.
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